As we have previously reported, Txnip deficiency in type 1 diabetic mice efficiently reduces blood glucose levels and ultimately increases mice survival, suggesting that Txnip may be a potential therapeutic target for the development of diseases such as diabetes [11]. Here, TXNIP is linked to diabetes mellitus.